Skip to main content
. 2012 Dec 20;7(12):e51395. doi: 10.1371/journal.pone.0051395

Figure 4. Oral glucose tolerance tests (OGTTs) at baseline and after 28 days treatment placebo (upper) SRT2104 0.5 g/day (middle) or SRT2104 2.0 g/day (lower panel).

Figure 4